Marion Merrell Dow Buys Remaining Interest of Nordic
KANSAS CITY, Mo. (AP) _ Drug maker Marion Merrell Dow Inc. has reached an agreement that will give it full ownership of Nordic Laboratories Inc. of Laval, Quebec, by buying the remaining 14.6 percent stake in the company.
The purchase, announced Tuesday, also means Marion Merrell Dow will coordinating the management of Nordic and Marion’s other Canadian affiliate, Merrell Dow Pharmaceuticals (Canada) Inc., under a single business entity known as Marion Merrell Dow (Canada) Inc.
Marion Merrell Dow is a $2.5 billion company based in Kansas City. It is involved in the research, development, manufacture and marketing of prescription and over-the-counter drugs.